
Zymeworks Announces FDA Clearance of Application for Liver Cancer Treatment Drug, ZW251
Zymeworks Announces FDA Clearance of Application for Liver Cancer Treatment Drug, ZW251 Second antibody-drug conjugate (ADC) to progress into clinical development utilizing our proprietary payload and optimized antibody Preclinical results demonstrate …